Treatment retention in adolescent patients treated with methadone or buprenorphine for opioid dependence: A file review

Drug and Alcohol Review

Volumn 25, Issue 2, 2006, Pages 167-171

  Bell, James ^a   Mutch, Carolyn ^a  

^a Langton Centre   (Australia)

Author keywords

Adolescent; Buprenorphine; Heroin; Methadone; Retention

Indexed keywords

BUPRENORPHINE; METHADONE; NARCOTIC AGENT; NARCOTIC ANTAGONIST;

ADOLESCENT; AUSTRALIA; COMPARATIVE STUDY; FEMALE; HUMAN; MALE; OPIATE ADDICTION; PATIENT; PATIENT COMPLIANCE; RETREATMENT; RETROSPECTIVE STUDY; REVIEW; STATISTICS;

ADOLESCENT; BUPRENORPHINE; FEMALE; HUMANS; MALE; METHADONE; NARCOTIC ANTAGONISTS; NARCOTICS; NEW SOUTH WALES; OPIOID-RELATED DISORDERS; PATIENT COMPLIANCE; PATIENT DROPOUTS; RETREATMENT; RETROSPECTIVE STUDIES;

EID: 33646449803     PISSN: 09595236     EISSN: 14653362     Source Type: Journal    
DOI: 10.1080/09595230500537670     Document Type: Review

References (16)

1. Hall WD, Ross JE, Lynskey MT, Law MG, Degenhardt LJ. How many dependent heroin users are there in Australia? Med J Aust 2000;173:528-31.
2. Lynskey M, Hall W. Age of initiation to heroin use: cohort trends and consequences of early initiation for subsequent adjustment. NDARC Technical Report no. 61. Sydney: University of New South Wales, National Drug and Alcohol Research Centre, 1998.
3. Hando J, Darke S. NSW drug trends 1997: findings from the Illicit Drug Reporting System (IDRS). NDARC Technical Report no. 56, Sydney: University of New South Wales, National Drug and Alcohol Research Centre, 1997.
4. Hopfer CJ, Khuri E, Crowley TJ, Hooks S. Adolescent heroin use: a review of the descriptive and treatment literature. J Subst Abuse Treat 2002;23:231-7.
5. Substance Abuse and Mental Health Services Administration. Summary of findings from the 2000 National Household Survey on Drug Abuse. Series H-13, DHHS Publication no. 01-3549. Rockville, MD: Office of Applied Studies, NHSDA, 2001.
6. Ball JC, Ross A. The effectiveness of methadone maintenance treatment: patients, programs, services and outcome. New York: Springer-Verlag, 1991.
7. Ward J, Mattick RP, Hall W. Methadone maintenance treatment and other opioid replacement therapies. Amsterdam: Harwood Academic Publishers, 1998.
8. Bell J, Zador D. A risk-benefit analysis of methadone maintenance treatment. Drug Safety 2000;22:179-90.
9. Crome IB, Christian J, Green C. Tip of the national iceberg? Profile of adolescent patients prescribed methadone in an innovative community drug service. Drug Educ Prev Policy 1998;5:195-7.
10. Boyd P, Layland WR, Crickmay JR. Treatment and followup of adolescents addicted to heroin. BMJ 1971;4:604-5.
11. Rosenberg CM, Patch VD. Methadone use in adolescent heroin addicts. JAMA 1972;220:991-3.
12. Millman RB, Khuri ET, Nyswander ME. Therapeutic detoxification of adolescent heroin addicts. Ann NY Acad Sci 1978;311:153-64.
13. Auriacombe M, Franques P, Tignol J. Deaths attributable to buprenorphine versus methadone in France [Letter]. JAMA 2001;285:45.
14. Gandhi D, Jaffe J, McNary S, Kavanagh G, Hayes M, Currens M. Short-term outcomes after brief ambulatory opioid detoxification with buprenorphine in young heroin users. Addiction 2003;98:453-62.
15. Mattick RP, Kimber J, Breen C, Davoli M. Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence. Cochrane Database Syst Rev 2003;(2):CD002207.
16. Dole VP, Nyswander ME, Kreek MJ. Narcotic blockade - a medical technique for stopping heroin use by addicts. Trans Assoc Am Physicians 1966;79:122-36.